Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Blog | June 14, 2024

Texas Patent Litigation Monthly Wrap-Up: May 2024

Article | June 13, 2024

AI and the Word That's Been Missing From Patent Eligibility Case Law

Blog | May 20, 2024

Want to Fully Protect Your Brand? Don’t Forget the Coffee Mugs!

Blog | May 09, 2024

Federal Circuit Reiterates That an Alleged Infringer’s Intent Is Irrelevant in a Hatch-Waxman Safe Harbor Analysis

Blog | May 01, 2024

Legal Alert: What the FTC’s Ban on Noncompete Agreements Means for Trade Secrets

Blog | April 29, 2024

Navigating SuperGuide at the PTAB

Blog | April 22, 2024

Legal Alert: USPTO Issues Proposed Rules on Discretionary Denial in PTAB Proceedings

Blog | April 17, 2024

Legal Alert: USPTO Issues Proposed Rules on Director Review

Blog | April 15, 2024

Hatch-Waxman 101

Blog | April 10, 2024

What’s New in Director Review? Lessons From the Delegated Rehearing Panel’s First Decisions.

Blog | April 05, 2024

Biologics and Biosimilars Landscape 2023: IP, Policy, and Market Developments

Article | March 28, 2024

When Does IPR Estoppel Apply to Product or System Art in District Court?